Natural compounds from herbs and nutraceuticals as glycogen synthase kinase‐3β inhibitors in Alzheimer's disease treatment DOI Creative Commons
Zheng Zhao, Ye Yuan, Shuang Li

и другие.

CNS Neuroscience & Therapeutics, Год журнала: 2024, Номер 30(8)

Опубликована: Авг. 1, 2024

Abstract Background Alzheimer's disease (AD) pathogenesis is complex. The pathophysiology not fully understood, and safe effective treatments are needed. Glycogen synthase kinase 3β (GSK‐3β) mediates AD progression through several signaling pathways. Recently, studies have found that various natural compounds from herbs nutraceuticals can significantly improve symptoms. Aims This review aims to provide a comprehensive summary of the potential neuroprotective impacts as inhibitors GSK‐3β in treatment AD. Materials Methods We conducted systematic literature search on PubMed, ScienceDirect, Web Science, Google Scholar, focusing vitro vivo investigated Results mechanism may be related activation inhibition regulate amyloid beta production, tau protein hyperphosphorylation, cell apoptosis, cellular inflammation. By reviewing recent phytochemicals intervention, flavonoids including oxyphylla A, quercetin, morin, icariin, linarin, genipin, isoorientin were reported potent for treatment. Polyphenols such schisandrin B, magnolol, dieckol inhibitory effects models, models. Sulforaphene, ginsenoside Rd, gypenoside XVII, falcarindiol, epibrassinolides, 1,8‐Cineole, andrographolide promising inhibitors. Conclusions Natural candidates They qualify derivatives development enhanced pharmacological characteristics.

Язык: Английский

Molecular characterization and structural basis of a promiscuous glycosyltransferase for β‐(1,6) oligoglucoside chain glycosides biosynthesis DOI Creative Commons

Zhennan Jiang,

Nianhang Chen,

Haotian Wang

и другие.

Plant Biotechnology Journal, Год журнала: 2025, Номер unknown

Опубликована: Март 19, 2025

Summary Sugar building blocks are crucial for the chemical diversity and biological activity of secondary metabolites. UDP‐dependent glycosyltransferases (UGTs) play a pivotal role in biosynthesis glycosides plants by catalysing attachment sugar moieties to various bioactive natural products. However, oligosaccharide‐chain is often limited narrow substrate specificity UGTs. In this study, we identify regio‐specific β ‐(1,6) glycosyltransferase, UGT94BY1, from Platycodon grandiflorum . UGT94BY1 exhibits broad promiscuity can transfer up three C6‐OH position glucosyl group triterpenoids phenolic glycosides, thereby forming oligoglucoside chains. To elucidate mechanism underlying its selectivity, determined crystal structure complex with UDP at resolution 2.0 Å. Molecular simulations revealed that critical structural motif, comprising residues N84‐M91, S141‐L155 R179‐E186, plays key recognizing acceptors facilitating chain elongation. Our study unveils powerful glycosyltransferase highlights regions involved recognition extension, providing valuable insights designing UGTs customized specificities biotechnological applications.

Язык: Английский

Процитировано

0

Inhibition of the pyroptosis-associated inflammasome pathway: The important potential mechanism of ginsenosides in ameliorating diabetes and its complications DOI
Pan Liu, Zhengdong Zhang, Yichen Cai

и другие.

European Journal of Medicinal Chemistry, Год журнала: 2023, Номер 253, С. 115336 - 115336

Опубликована: Апрель 5, 2023

Язык: Английский

Процитировано

12

Review of probiotics, gut microorganisms, and their enzymes involved in the conversion of ginsenosides DOI
Mingjun Li, Zunxi Huang, R. Zhang

и другие.

Food Bioscience, Год журнала: 2024, Номер 58, С. 103829 - 103829

Опубликована: Март 3, 2024

Язык: Английский

Процитировано

4

Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer DOI Creative Commons
Xiyu Liu, Jingjing Li, Qingqing Huang

и другие.

Molecular Medicine, Год журнала: 2024, Номер 30(1)

Опубликована: Апрель 26, 2024

Ginsenoside Rh2 (G-Rh2), a steroidal compound extracted from roots of ginseng, has been extensively studied in tumor therapy. However, its specific regulatory mechanism non-small cell lung cancer (NSCLC) is not well understood. Pyruvate dehydrogenase kinase 4 (PDK4), central regulator cellular energy metabolism, highly expressed various malignant tumors. We investigated the impact G-Rh2 on progression NSCLC and how it regulated PDK4 to influence aerobic glycolysis mitochondrial function.

Язык: Английский

Процитировано

4

Natural compounds from herbs and nutraceuticals as glycogen synthase kinase‐3β inhibitors in Alzheimer's disease treatment DOI Creative Commons
Zheng Zhao, Ye Yuan, Shuang Li

и другие.

CNS Neuroscience & Therapeutics, Год журнала: 2024, Номер 30(8)

Опубликована: Авг. 1, 2024

Abstract Background Alzheimer's disease (AD) pathogenesis is complex. The pathophysiology not fully understood, and safe effective treatments are needed. Glycogen synthase kinase 3β (GSK‐3β) mediates AD progression through several signaling pathways. Recently, studies have found that various natural compounds from herbs nutraceuticals can significantly improve symptoms. Aims This review aims to provide a comprehensive summary of the potential neuroprotective impacts as inhibitors GSK‐3β in treatment AD. Materials Methods We conducted systematic literature search on PubMed, ScienceDirect, Web Science, Google Scholar, focusing vitro vivo investigated Results mechanism may be related activation inhibition regulate amyloid beta production, tau protein hyperphosphorylation, cell apoptosis, cellular inflammation. By reviewing recent phytochemicals intervention, flavonoids including oxyphylla A, quercetin, morin, icariin, linarin, genipin, isoorientin were reported potent for treatment. Polyphenols such schisandrin B, magnolol, dieckol inhibitory effects models, models. Sulforaphene, ginsenoside Rd, gypenoside XVII, falcarindiol, epibrassinolides, 1,8‐Cineole, andrographolide promising inhibitors. Conclusions Natural candidates They qualify derivatives development enhanced pharmacological characteristics.

Язык: Английский

Процитировано

4